【24h】

Minor extended-spectrum beta-lactamases.

机译:次要广谱β-内酰胺酶。

获取原文
获取原文并翻译 | 示例
           

摘要

Extended-spectrum beta-lactamases (ESBLs) are usually plasmid-mediated enzymes that confer resistance to a broad range of beta-lactams. Initially, resistance to third-generation cephalosporins in Gram-negative rods was mainly due to the dissemination of TEM- and SHV-type ESBLs, which are point mutants of the classic TEM and SHV enzymes with extended substrate specificity. During the last ten years, CTX-M-type ESBLs have become increasingly predominant, but less frequent class A beta-lactamases have also been described, including SFO, BES, BEL, TLA, GES, PER and VEB types. While several of these latter are rarely identified, or are very localised, others are becoming locally prevalent, or are increasingly isolated worldwide. In addition, mutations can extend the spectrum of some OXA-type beta-lactamases to include expanded-spectrum cephalosporins, and several of these enzymes are considered to be ESBLs.
机译:广谱β-内酰胺酶(ESBLs)通常是质粒介导的酶,可赋予广泛的β-内酰胺抗性。最初,革兰氏阴性棒对第三代头孢菌素的耐药性主要归因于TEM和SHV型ESBL的传播,它们是经典TEM和SHV酶的点突变体,具有扩展的底物特异性。在过去的十年中,CTX-M型ESBL越来越占主导地位,但是也已经描述了频率较低的A类β-内酰胺酶,包括SFO,BES,BEL,TLA,GES,PER和VEB类型。尽管其中的一些很少被发现或非常局部化,但其他的则在当地变得普遍,或者在世界范围内越来越孤立。另外,突变可以扩展某些OXA型β-内酰胺酶的谱,使其包括扩谱的头孢菌素,这些酶中的几种被认为是ESBLs。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号